Areteia Therapeutics Funding: $350M Series A, Bain Capital

Areteia Therapeutics, based in Chapel Hill, NC, has raised $350M in total through a Series A round backed by Bain Capital.

Areteia Therapeutics funding overview

Areteia Therapeutics is based in Chapel Hill, NC. Areteia Therapeutics has raised $350M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Areteia Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Bain Capital.

Areteia Therapeutics at a glance

Total raised
$350M
Latest round
Series A
Latest round date
January 2024
Headquarters
Chapel Hill, NC
Notable investors
Bain Capital

Frequently asked about Areteia Therapeutics funding

How much has Areteia Therapeutics raised?
Areteia Therapeutics has raised $350M in total disclosed funding across the rounds on record.
Who has invested in Areteia Therapeutics?
Bain Capital are named among the investors backing Areteia Therapeutics.
What was the latest Areteia Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2024.
Where is Areteia Therapeutics based?
Areteia Therapeutics is based in Chapel Hill, NC.
When did Areteia Therapeutics last raise?
The last disclosed Areteia Therapeutics round closed in January 2024 at Series A.

Round data for Areteia Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Chapel Hill and backer lists below.

Areteia Therapeutics funding history

3 disclosed rounds on record, including 2 reported through SEC Form D filings.

  1. Filed February 2025 — Private financing. $360M sold of a $445M offering. 16 investors reported. SEC Form D filing
  2. Filed February 2024 — Private financing. $275M sold of a $445M offering. 13 investors reported. SEC Form D filing
  3. January 2024 — Series A. $350M.

SEC Form D filings report the amount sold against a stated offering size, which can differ from press-reported round totals, and they do not name the round — those entries appear as Private financing.

Companies related to Areteia Therapeutics (24)

Browse related funding lists (4)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades